327 related articles for article (PubMed ID: 23600521)
21. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
22. Chemokine and cytokine levels in inflammatory bowel disease patients.
Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
[TBL] [Abstract][Full Text] [Related]
23. Circulating and Tissue-Resident CD4
Hegazy AN; West NR; Stubbington MJT; Wendt E; Suijker KIM; Datsi A; This S; Danne C; Campion S; Duncan SH; Owens BMJ; Uhlig HH; McMichael A; ; Bergthaler A; Teichmann SA; Keshav S; Powrie F
Gastroenterology; 2017 Nov; 153(5):1320-1337.e16. PubMed ID: 28782508
[TBL] [Abstract][Full Text] [Related]
24. Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.
Philippe D; Chakass D; Thuru X; Zerbib P; Tsicopoulos A; Geboes K; Bulois P; Breisse M; Vorng H; Gay J; Colombel JF; Desreumaux P; Chamaillard M
Gut; 2006 Jun; 55(6):815-23. PubMed ID: 16299031
[TBL] [Abstract][Full Text] [Related]
25. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
[TBL] [Abstract][Full Text] [Related]
26. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.
Kamat A; Ancuta P; Blumberg RS; Gabuzda D
PLoS One; 2010 Nov; 5(11):e15533. PubMed ID: 21125014
[TBL] [Abstract][Full Text] [Related]
27. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
28. High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.
Liu AY; De Rosa SC; Guthrie BL; Choi RY; Kerubo-Bosire R; Richardson BA; Kiarie J; Farquhar C; Lohman-Payne B
Immun Inflamm Dis; 2018 Sep; 6(3):392-401. PubMed ID: 29974672
[TBL] [Abstract][Full Text] [Related]
29. Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients.
Tincati C; Bellistrì GM; Ancona G; Merlini E; d'Arminio Monforte A; Marchetti G
Clin Dev Immunol; 2012; 2012():935425. PubMed ID: 22400042
[TBL] [Abstract][Full Text] [Related]
30. Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study.
Furuzawa-Carballeda J; Fonseca-Camarillo G; Lima G; Yamamoto-Furusho JK
Clin Dev Immunol; 2013; 2013():278035. PubMed ID: 24282429
[TBL] [Abstract][Full Text] [Related]
31. Variation in gut-homing CD27-negative lymphocytes in inflammatory colon disease.
Meenan J; Spaans J; Grool TA; Lammers K; Pals S; Tytgat GN; van Deventer SJ
Scand J Immunol; 1998 Sep; 48(3):318-23. PubMed ID: 9743220
[TBL] [Abstract][Full Text] [Related]
32. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
33. Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry.
Neil GA; Summers RW; Cheyne BA; Carpenter C; Huang WL; Waldschmidt TJ
Dig Dis Sci; 1994 Sep; 39(9):1900-8. PubMed ID: 8082496
[TBL] [Abstract][Full Text] [Related]
34. Crossover Subsets of CD4
Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
[TBL] [Abstract][Full Text] [Related]
35. Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.
Islam D; Bardhan PK; Lindberg AA; Christensson B
Infect Immun; 1995 Aug; 63(8):2941-9. PubMed ID: 7622216
[TBL] [Abstract][Full Text] [Related]
36. Fuzhengpaidu granule regulates immune activation molecules CD38 and human leukocyte antigen-D related on CD4+ and CD8+ T cells in patients with acquired immunodeficiency syndrome/human immunodeficiency virus.
Jiang F; Zhang R; Gu Z; Zhang H; Guo H; Deng X; Liang J
J Tradit Chin Med; 2013 Aug; 33(4):439-43. PubMed ID: 24187862
[TBL] [Abstract][Full Text] [Related]
37. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
38. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
[TBL] [Abstract][Full Text] [Related]
39. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
40. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
Giorgi JV; Ho HN; Hirji K; Chou CC; Hultin LE; O'Rourke S; Park L; Margolick JB; Ferbas J; Phair JP
J Infect Dis; 1994 Oct; 170(4):775-81. PubMed ID: 7930717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
